Evaluation of the impact of single-nucleotide polymorphisms on treatment response, survival and toxicity with cytarabine and anthracyclines in patients with acute myeloid leukaemia: a systematic review protocol
DiscussionIt is expected that clinical decisions for AML patients will consider evidence-based practices to contribute to better patient management. In this way, we will be able to define how to treat patients with AML to improve their survival and quality of life.Systematic review registrationPROSPEROCRD42018100750
Source: Systematic Reviews - Category: International Medicine & Public Health Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Cancer | Cancer & Oncology | Chemotherapy | Clinical Trials | Databases & Libraries | Genetics | International Medicine & Public Health | Leukemia | Study | Toxicology